Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Novel approach to amoebic gill disease in salmon could benefit humans
Amoebic gill disease is a major disease of farmed Atlantic salmon.

Scientists to repurpose drugs used to treat human parasitic diseases.

Researchers at the University of Glasgow are developing a novel approach to the treatment of amoebic gill disease that could drive down the cost of drugs currently used to treat parasitic diseases in humans.

Caused by the parasite Neoparamoeba perurans, amoebic gill disease (AGD) is major disease of farmed Atrlantic salmon, resulting in severe economic losses across the world. The parasite causes proliferative gill disease, with symptoms including increased mucus on the gills, swollen tissue and breathing difficulties.

In the study, scientists propose to repurpose drugs used to treat human parasitic diseases, such as sleeping sickness, Chagas disease and leishmaniasis, to manage AGD in Atlantic salmon.

Using the University's 'drug discovery pipeline', researchers propose to test the potency of these drugs against Neoparamoeba perurans. The team will then test a candidate drug for activity against ADG in Atlantic salmon at a marine trial site in Ireland.

Researchers hope that by opening new markets for these drugs, it will drive down the cost of parasitic treatment in humans, particularly in the developing world where unaffordable healthcare can lead to millions of unnecessary deaths.

Study co-author Dr Martin Llewellyn, said: “This project is a great opportunity to understand some of the science behind symbiosis, develop a much-needed drug for salmon aquaculture and also hopefully have a beneficial impact on the treatment of diseases that impact the lives of hundreds of millions of people in the tropics.”

Funded by the BBSRC, the project will involve a collaboration with the Marine Institute, Ireland and Dalhousie University, Canada.

Become a member or log in to add this story to your CPD history

Boehringer Ingelheim to host online Christmas comedy special

News Story 1
 Boehringer Ingelheim (BI) Animal Health is set to host a live Christmas comedy event to provide entertainment and festive fun for veterinary professionals.

BI Animal Health's Christmas Comedy Cracker is a free online event, designed to help veterinary professionals sit back and relax at the end of what has been a difficult year for the whole profession.

The event will take place online at 8pm on Thursday 17 December. Comedian Rhys James will host and the line-up also includes ventriloquist Nina Conti, comedian Zoe Lyons and musical comedy troupe The Noise Next Door.

To register your place for free please visit www.christmascomedycracker.co.uk 

Click here for more...
News Shorts
VMD and VPS announce joint open information day

The Veterinary Medicines Directorate (VMD) and the Veterinary Products Committee (VPC) have announced a joint open information day covering topics such as veterinary medicines regulations, antimicrobial resistance, scientific advice and novel therapies.

Taking place on Wednesday 18 November, the virtual event will take the form of a series of pre-recorded webinars and a 'Slido' Q&A session. Links to the webinars and full instructions on how to use Slido will be available on gov.uk on 18 November. To join the mailing list for the event, email director.support@vmd.gov.uk